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Abstract Mouse brown adipocytes in primary culture were 
shown to contain high levels of mRNA for interleukin-la (IL-la) 
which could be further stimulated up to 9-fold by norepinephrine 
(NE). Even higher stimulation by NE, up to 40-fold, was found in 
case of interleukin-6 (IL-6). Time-course of activation of both 
genes was biphasic, but the response of IL-6 gene was slower 
than of IL-la gene. IL-la mRNA level reached the maximum 
after 1 h and the second, lower increase, occurred after 8 h. IL-6 
mRNA level showed first maximum after 2 h, but the highest 
level was found after 8 h. Similarly to NE, the expression of IL-
la and IL-6 genes was stimulated by selective P-adrenergic 
agonist isoproterenol, p3-selective agonist CGP-12117, forsko-
line and db-cAMP. The activation of both genes by CGP-12177 
was dose-dependent with the optimum at 100 nM concentration. 
Stimulation of oc-adrenergic receptors by cirazoline and oxyme-
tazoline was without any effect. When the expression of IL-6 was 
studied at the protein level, the stimulation of IL-6 gene via Pa-
receptors resulted in secretion of IL-6 up to the concentration 10 
ng/ml culture media in 24 h. The results indicate a new type of 
regulation of expression of IL-la and IL-6 genes in brown 
adipocytes by catecholamines acting via p3-adrenergic receptors. 
The resulting increase in IL-6 production by brown adipocytes 
could significantly contribute to systemic levels of IL-6. 
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1. Introduction 
Norepinephrine (NE) is a key regulator of brown adipose 
tissue (BAT) functions. In long-term action NE stimulates 
protein synthesis, proliferation and growth of BAT during 
ontogenic recruitment process or cold adaptation. NE acts 
also as an acute inducer of thermogenic activity of BAT by 
activating free-fatty acids oxidation-heat production cascade 
[1]. It has been shown that NE-stimulated proliferation of 
BAT cells is mediated mainly via pi-receptors, while the 
NE-induced differentiation is mediated via p3-receptors [2]. 
P3-Receptors are also responsible for the activation of heat 
production in differentiated BAT cells. An active role of BAT 
thermogenesis in acute fever development was reported, and it 
was ascribed to central effect of IL-ip and TNFa [3,4]. These 
cytokines were also found to stimulate the expression of IL-la 
directly in cultured BAT cells [5]. Moreover, we have found 
that IL-la mRNA level in BAT cells was significantly influ-
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enced by NE, which indicated another role of catecholamines 
in BAT. Therefore, in this report we studied the influence of 
adrenergic hormones on the expression of two cytokine genes 
IL-la and IL-6 in BAT. These proinflammatory cytokines are 
potent endogenous pyrogens with pleiotropic action. IL-la is 
an early-acting inducer of other inflammatory cytokines in-
cluding IL-1, TNF-a, IL-6, IL-8 and interferons [6,7]. IL-6 
is not able to stimulate IL-la or IL-6 production, however, 
it is critical for terminal differentiation of B lymphocytes and 
for the synthesis of acute phase proteins in liver [8-10]. In this 
work we found, that adrenergic stimulation of cultured brown 
adipocytes activates via P3-adrenergic receptors the transcrip-
tion of both IL-la and IL-6 genes and it also induces inten-
sive secretion of IL-6 into the cultivation medium. 
2. Materials and methods 
2.1. Reagents 
NE, selective adrenergic agonists and antagonists, db-cAMP and 
forskoline were obtained from Sigma. To avoid possible endotoxin 
contamination, all solutions were filtered through 0.22 um filter. 
2.2. Primary cell culture of BAT 
Stromal-vascular cells from interscapular, subscapular and cervical 
BAT were prepared and cultivated as before [11] in a modified 
EMEM containing Earle's salts and supplemented with ascorbate, 
glutamine, insulin, gentamicin, glucose and 10% FCS. 
2.3. RNA isolation and Northern blot analysis 
Cultured cells were washed with PBS prior to total RNA isolation 
according to the guanidinium/phenol/chloroform procedure [12]. 
Northern blots (20 ug total RNA aliquots) were sequentially hybri-
dized with cDNA probes radiolabeled with [a-32P]dCTP (3000 Ci/ 
mmol) using the Random Priming Kit (Boehringer Mannheim) essen-
tially as before [13]. Mouse IL-la cDNA was 1.6-kbp fragment cut by 
PstI and EcoKl from the pILHOl plasmid provided by P.T. Lomedi-
co (Hoffmann-La Roche, Nutley, USA) [14]. Mouse IL-6 cDNA (1.1-
kbp EcoRI fragment) was kindly provided by Van Snick (Ludwig 
Institute for Cancer Research, Brussels, Belgium) [15]. The probe 
for p-actin was identical with that used earlier [13]. Radioactivity 
on the membranes was quantified by Phosphorlmager analysis system 
(Molecular Dynamics). The IL-la mRNA and IL-6 mRNA values 
obtained were normalized with respect to the $-actin mRNA signal. 
2.4. Measurement of IL-6 protein 
IL-6 in culture supernatants was quantified using ELISA kit from 
Amersham (Biotrak RPN 2714), according to the specifications of the 
manufacturer. The lower limit of the detection was 15 pg/ml and the 
values were determined by comparison with an IL-6 standard from 
Amersham. 
3. Results 
3.1. Effect of norepinephrine on IL-la and IL-6 mRNA levels 
in cultured brown adipocytes 
Addition of NE to differentiated BAT cells significantly 
increases steady state levels of IL-la as well as IL-6 
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mRNA. In both cases the response was biphasic, but the 
stimulation of IL-la was different from IL-6 (NE, Fig. 1). 
The IL-la mRNA level was significantly elevated already 
after 15 min and reached the maximum after 1 h of NE 
stimulation, similarly as we observed in previous studies on 
stimulation of IL-la mRNA by inflammatory cytokines [5]. 
IL-la mRNA level increased approximately 9 times after 1 h 
and the secondary 4-fold increase occurred after 8 h of NE 
stimulation, compared with the levels of non-stimulated con-
trols. 
The response of the IL-6 gene was more prolonged and 
showed also two maxima. The first, smaller activation peaked 
after 2 h and the major, second phase increase occurred after 
8 h of NE stimulation. The IL-6 mRNA levels were thus 
stimulated 10 times and 37 times, respectively. The expression 
of both genes was still elevated after 16 h of NE stimulation, 
resulting in 3-fold increase of IL-la mRNA and 10-fold in-
crease of IL-6 mRNA levels. 
3.2. Characterisation of adrenernergic receptors involved in 
regulation of IL-la and IL-6 genes 
In order to identify the subtypes of adrenergic receptors 
involved in NE stimulation of cytokine gene expression in 
brown adipocytes, we studied the levels of IL-la and IL-6 
mRNAs after stimulation with different adrenergic agonists. 
As both IL-la and IL-6 mRNA levels were sufficiently ele-
vated after 1 h incubation of BAT cells with NE, we chose 
this time period to follow the effect of subtype specific adre-
nergic agonists. As seen in Fig. 2, selective oci -adrenergic ago-
nists cirazoline and oxymetazoline had no effect on the ex-
pression of IL-la and IL-6 genes even at 10 |jM 
concentration. In contrast, (3-selective agonist isoproterenol 
stimulated at the 1 uM concentration the levels of IL-la 
and IL-6 transcripts nearly as much as NE (90% of NE 
values). Almost identical stimulation was found with p3-spe-
cific agonist CGP-12117 (1 pM), which also exerts strong 
Pi-antagonistic effect in brown adipocytes [2]. No effect was 
observed after stimulation with p2 -agonist procaterol 
(1 LiM). 
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Fig. 1. Induction of IL-la and IL-6 gene expression by NE in cul-
tured brown adipocytes. Brown adipocytes cultured for 8 days were 
stimulated by 1 |xM NE and RNA was isolated at 15 min, 30 min, 
1, 2, 4, 8 and 16 h after NE addition. 20 ug aliquots of RNA were 
analysed by Northern blotting using IL-la, IL-6 and ft-actin cDNA 
probes. The IL-la and IL-6 mRNA values were corrected with re-
spect to fi-actin mRNA levels and expressed in percent of non-
stimulated control as the means! S.E.M. of three independent ex-
periments. 
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Fig. 2. Pharmacological characteristics of adrenergic stimulation of 
IL-la and IL-6 gene expression in cultured brown adipocytes. 
Brown adipocytes cultured for 8 days were stimulated by NE (1 
LIM), isoprenaline (Iso, 1 uM), CGP 12177 (1 uM), procaterol (Pro, 
1 uM), cirazoline (Cir, 10 uM), oxymetazoline (Oxy, 10 uM), dibu-
tyryl-cAMP (cAMP, 10 mM) and forskoline (For, 1 uM). RNA 
was isolated at 1 h after stimulation and quantified by Northern 
blotting as in Fig. 1. The values are expressed in percent of non-
stimulated control (C) and are means ± S.E.M. of three independent 
experiments. 
Expression of both genes was also highly stimulated (75-
85% of NE values) by db-cAMP (10 mM) or after activation 
of adenylyl cyclase with forskoline (1 p,M). 
3.3. Dose response of CGP-12117 stimulation of IL-la and 
IL-6 genes 
The levels of IL-la and IL-6 transcripts in brown adipo-
cytes were further measured after 1 h incubation using differ-
ent concentrations of CGP-12117 (Fig. 3). The results showed 
that CGP-12117 increased the transcription of both genes in 
dose-dependent manner. Significant stimulation of both genes 
occurred from 10 nM CGP-12117 with a plateau at 102 104 
nM agonist. The profile of CGP stimulation observed is in 
accordance with other studies, and corresponds with the sat-
uration of CGP-12177 binding sites on the surface of brown 
adipocytes [16]. From pharmacological point of view it seems, 
that the activation of both IL-la and IL-6 genes during the 
rapid, 1 h stimulation is very similar and it may involve the 
same transcription factors participating in signalling pathways 
of p3-adrenergic receptors. 
3.4. Secretion of IL-6 protein into cultivation medium 
The stimulation of brown adipocytes by NE resulted also in 
synthesis and secretion of IL-6 into the cultivation medium, as 
shown by measurements of the amount of IL-6 protein by 
ELISA assay 24 h after stimulation. We found (Fig. 4), that 
brown adipocytes in primary culture secrete IL-6 at a rate 
8 ng/ml/24 h after 1 u,M NE stimulation. The IL-6 secretion 
was similarly induced by CGP-12177 and by forskoline, but 
cirazoline had not any effect on IL-6 secretion. The IL-6 
changes in medium thus follow the corresponding changes 
of IL-6 mRNA in the cells. 
We conclude that IL-6 gene transcription could be activated 
by p3-adrenergic receptors and this signal is sufficient for IL-6 
synthesis and secretion under conditions when serum is 
present in culture medium. 
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4. Discussion 
NE stimulates IL-la and IL-6 mRNAs most probably due 
to activated transcription of these genes. In both cases the 
response shows two phases. The first response, which occurs 
in 1 h, is apparently mediated mainly via pVadrenergic recep-
tors signalling pathways which includes increase in intracellu-
lar cAMP, arachidonic acid and stimulation of protein kinase 
A. Stimulation of a-receptors, which are known to activate 
protein kinase C signalling pathway, is without any effect. The 
second phase, more pronounced in IL-6 stimulation, occurred 
at about 8 h and can be of more complex character. It is 
probable, that after such a long time period autocrine or para-
crine effect of newly synthesised IL-la or of other factors (for 
example arachidonic acid metabolites) could occur. 
It is generally accepted, that many cell types in culture do 
not constitutively express IL-6 at protein level. Stimulation of 
IL-6 synthesis requires at least two signals, while one signal is 
sufficient only for mRNA synthesis in fibroblasts [17]. For this 
reason and because serum conditions better reflects physiolog-
ical environment, we performed all the experiments in the 
presence of 10% serum. It is known that (3-adrenergic recep-
tors are coupled via G-proteins with adenylate cyclase and its 
activation results in elevated intracellular levels of cAMP. 
Stimulatory effect of NE, CGP-12177 or forskoline in the 
presence of serum on IL-6 gene expression is in agreement 
with the presence of cAMP (CRE) and serum (SRE) respon-
sive elements in IL-6 promoter region [18]. 
We show, that stimulation of brown adipocytes by physio-
logical concentration of NE results in activated transcription 
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Fig. 3. Dependence of IL-la and IL-6 mRNA levels on the concen-
tration of pVselective agonist CGP 12177. Brown adipocytes cul-
tured for 8 days were stimulated by indicated concentrations of 
CGP 12177. Total RNA was isolated at 1 h after stimulation and 
quantified by Northern blotting as in Fig. 1. The values are ex-
pressed in percent of non-stimulated control and are means ± S.E.M. 
of three independent experiments. The picture is representative sam-
ple. 
Fig. 4. Secretion of IL-6 by brown adipocytes after adrenergic stim-
ulation. Brown adipocytes cultured for 8 days (control, C) were 
stimulated by 1 uM concentration of NE, CGP 12177 and forskolin 
(For), and by cirazoline (Cir, 10 uM). The amount of IL-6 secreted 
into the cultivation medium was analysed by ELISA system. The 
values are expressed in ng/ml of IL-6 observed 24 h after stimula-
tion. The data are means ± S.E.M. of three independent experi-
ments. 
and secretion of IL-6 into the cultivation medium up to 10 ng/ 
ml per 24 h. Similar IL-6 concentration in serum were suffi-
cient to activate most of the IL-6 biological functions includ-
ing synthesis of acute phase proteins by hepatocytes [19,20]. 
The physiological relevance of IL-6 release by BAT remains 
open. Our preliminary data indicate, that brown fat cells are 
sensitive to extracellular IL-6 and it could be therefore possi-
ble, that IL-6 produced by BAT could play a paracrine role. 
Considering high vascularization of BAT and pronounced 
amount of secreted IL-6 it is possible however, that BAT 
could contribute also to the systemic level of IL-6 under cer-
tain physiological conditions. Interestingly, BAT is also 
known to function as an endocrine tissue, as it was reported, 
that BAT actively deiodinates thyroxin and produces large 
amount of triiodothyronine into blood during cold adaptation 
in mouse [21]. IL-6 has been reported to act in wound healing 
[22], growth promotion and terminal differentiation of several 
immunocompetent cell types and stimulation of acute phase 
proteosynthesis in liver [18]. At several stressory states or cold 
stimulation characterised by sympathic activation, rapid re-
lease of catecholamines and glucocorticoids by adrenal gland 
leads to mobilisation of energy resources and immune func-
tions to keep an organism alive. As a result of our work, we 
demonstrate that catecholamines can also activate production 
of IL-la and IL-6 inflammatory cytokines in somatic cells of 
BAT. 
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